Bigfoot Biomedical Unity

Bigfoot Biomedical’s smart insulin pen cap [Image from Bigfoot Biomedical]

For close to 20 years, Jeffrey Brewer has focused on finding ways to support insulin delivery and manage diabetes.

Mazlish was the first person in the world to hack into an insulin pump and continuous glucose monitor (CGM) and enable a do-it-yourself closed-loop insulin dosing system, Brewer told Drug Delivery Business News.

“It turned my attention to the opportunities as an entrepreneur that I might be able to pursue, and then doing so with him, to see what we could add to the equation in terms of industry and how you can take technologies and make them usable and easy and ultimately make life more convenient, easy and safe for people with insulin-requiring diabetes,” said Brewer, who is CEO of Bigfoot. “We’ve been on this journey for about seven years now.”

Initially an entrepreneur, Brewer got involved with the Juvenile Diabetes Research Foundation (JDRF) and the Artificial Pancreas Project for developing a closed-loop insulin delivery system after his son was diagnosed with type 1 diabetes. After spending about four years as JDRF’s CEO, Brewer partnered with Bryan Mazlish — whose son also received a type 1 diagnosis — in 2014 to launch Bigfoot Biomedical.

Get the full story at our sister site, Drug Delivery Business News.